A new hormonal therapy for prostatic cancer: long-term clinical and hormonal response. 1986

S R Ahmed, and J B Grant, and S M Shalet, and A Howell, and C B Costello, and T Weatherson, and N J Blacklock

Twenty-four patients with advanced prostatic cancer were treated with daily injections of the LHRH analogue ICI 118630 (Zoladex) for up to 2 1/2 years. Successful long-term suppression of LH (luteinising hormone) and testosterone was observed without any escape of testosterone. Immunoreactive LH concentrations rose significantly following the daily injection of LHRH analogue but there was no corresponding rise in testosterone concentrations, suggesting altered bioactivity of the LH. A long-term clinical response was obtained in 10 patients (41.6%) and the median duration of response in these patients was 25 months. Eight of the 10 had well to moderately differentiated tumours. The actuarial median survival of all patients was 22 months.

UI MeSH Term Description Entries
D007986 Luteinizing Hormone A major gonadotropin secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). Luteinizing hormone regulates steroid production by the interstitial cells of the TESTIS and the OVARY. The preovulatory LUTEINIZING HORMONE surge in females induces OVULATION, and subsequent LUTEINIZATION of the follicle. LUTEINIZING HORMONE consists of two noncovalently linked subunits, alpha and beta. Within a species, the alpha subunit is common in the three pituitary glycoprotein hormones (TSH, LH and FSH), but the beta subunit is unique and confers its biological specificity. ICSH (Interstitial Cell Stimulating Hormone),Interstitial Cell-Stimulating Hormone,LH (Luteinizing Hormone),Lutropin,Luteoziman,Luteozyman,Hormone, Interstitial Cell-Stimulating,Hormone, Luteinizing,Interstitial Cell Stimulating Hormone
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011471 Prostatic Neoplasms Tumors or cancer of the PROSTATE. Cancer of Prostate,Prostate Cancer,Cancer of the Prostate,Neoplasms, Prostate,Neoplasms, Prostatic,Prostate Neoplasms,Prostatic Cancer,Cancer, Prostate,Cancer, Prostatic,Cancers, Prostate,Cancers, Prostatic,Neoplasm, Prostate,Neoplasm, Prostatic,Prostate Cancers,Prostate Neoplasm,Prostatic Cancers,Prostatic Neoplasm
D002064 Buserelin A potent synthetic analog of GONADOTROPIN-RELEASING HORMONE with D-serine substitution at residue 6, glycine10 deletion, and other modifications. Bigonist,Buserelin Acetate,HOE-766,Profact,Receptal,Suprecur,Suprefact,Tiloryth,Acetate, Buserelin,HOE 766,HOE766
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old
D013739 Testosterone A potent androgenic steroid and major product secreted by the LEYDIG CELLS of the TESTIS. Its production is stimulated by LUTEINIZING HORMONE from the PITUITARY GLAND. In turn, testosterone exerts feedback control of the pituitary LH and FSH secretion. Depending on the tissues, testosterone can be further converted to DIHYDROTESTOSTERONE or ESTRADIOL. 17-beta-Hydroxy-4-Androsten-3-one,17-beta-Hydroxy-8 alpha-4-Androsten-3-one,8-Isotestosterone,AndroGel,Androderm,Andropatch,Androtop,Histerone,Sterotate,Sustanon,Testim,Testoderm,Testolin,Testopel,Testosterone Sulfate,17 beta Hydroxy 4 Androsten 3 one,17 beta Hydroxy 8 alpha 4 Androsten 3 one,8 Isotestosterone
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

S R Ahmed, and J B Grant, and S M Shalet, and A Howell, and C B Costello, and T Weatherson, and N J Blacklock
August 1979, The Journal of urology,
S R Ahmed, and J B Grant, and S M Shalet, and A Howell, and C B Costello, and T Weatherson, and N J Blacklock
May 1951, Medecine et hygiene,
S R Ahmed, and J B Grant, and S M Shalet, and A Howell, and C B Costello, and T Weatherson, and N J Blacklock
April 1980, Cancer,
S R Ahmed, and J B Grant, and S M Shalet, and A Howell, and C B Costello, and T Weatherson, and N J Blacklock
April 1980, Cancer,
S R Ahmed, and J B Grant, and S M Shalet, and A Howell, and C B Costello, and T Weatherson, and N J Blacklock
April 1985, The Journal of urology,
S R Ahmed, and J B Grant, and S M Shalet, and A Howell, and C B Costello, and T Weatherson, and N J Blacklock
March 1986, Obstetrics and gynecology,
S R Ahmed, and J B Grant, and S M Shalet, and A Howell, and C B Costello, and T Weatherson, and N J Blacklock
December 2011, Expert review of pharmacoeconomics & outcomes research,
S R Ahmed, and J B Grant, and S M Shalet, and A Howell, and C B Costello, and T Weatherson, and N J Blacklock
January 1989, Oncology,
S R Ahmed, and J B Grant, and S M Shalet, and A Howell, and C B Costello, and T Weatherson, and N J Blacklock
April 2003, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie,
S R Ahmed, and J B Grant, and S M Shalet, and A Howell, and C B Costello, and T Weatherson, and N J Blacklock
September 1986, The Journal of urology,
Copied contents to your clipboard!